Index
RUT
P/E
-
EPS (ttm)
-3.12
Insider Own
17.30%
Shs Outstand
20.21M
Perf Week
-0.22%
Market Cap
367.74M
Forward P/E
20.11
EPS next Y
0.91
Insider Trans
-1.20%
Shs Float
16.71M
Perf Month
17.04%
Enterprise Value
326.41M
PEG
-
EPS next Q
0.23
Inst Own
80.02%
Perf Quarter
55.56%
Income
-62.79M
P/S
4.57
EPS this Y
-15.78%
Inst Trans
-0.28%
Perf Half Y
-5.85%
Sales
80.53M
P/B
2.75
EPS next Y
4.32%
ROA
-36.09%
Perf YTD
-0.16%
Book/sh
6.62
P/C
8.79
EPS next 5Y
-
ROE
-38.84%
52W High
21.01 -13.37%
Perf Year
6.31%
Cash/sh
2.07
P/FCF
15.47
EPS past 3/5Y
- -
ROIC
-46.81%
52W Low
11.09 64.11%
Perf 3Y
-59.32%
EV/EBITDA
19.66
Sales past 3/5Y
13.67% 13.74%
Gross Margin
61.48%
Volatility
0.61% 3.69%
Perf 5Y
-66.00%
EV/Sales
4.05
EPS Y/Y TTM
-962.01%
Oper. Margin
12.41%
ATR (14)
0.61
Perf 10Y
168.83%
Quick Ratio
5.47
Sales Y/Y TTM
2.51%
Profit Margin
-77.96%
RSI (14)
67.10
Current Ratio
5.47
EPS Q/Q
47.76%
SMA20
6.17%
Beta
1.29
Debt/Eq
0.00
Sales Q/Q
8.29%
SMA50
15.63%
Rel Volume
2.76
Prev Close
18.14
Employees
213
LT Debt/Eq
0.00
SMA200
15.10%
Avg Volume
420.44K
Price
18.20
IPO
Jun 18, 1997
Option/Short
Yes / Yes
Trades
Volume
1,160,995
Change
0.33%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-18-25 Downgrade
BTIG Research
Buy → Neutral
Sep-30-25 Initiated
TD Cowen
Hold
$16
Jul-15-25 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Nov-15-24 Initiated
Stephens
Overweight
$39
Jul-29-24 Initiated
KeyBanc Capital Markets
Overweight
$47
Jul-16-24 Initiated
JMP Securities
Mkt Perform
Jun-28-24 Initiated
William Blair
Outperform
May-09-23 Initiated
BTIG Research
Buy
$55
Oct-26-21 Upgrade
Craig Hallum
Hold → Buy
$65 → $53
Jan-12-21 Downgrade
Craig Hallum
Buy → Hold
Oct-16-20 Initiated
Raymond James
Outperform
$95
Sep-08-20 Initiated
Oppenheimer
Outperform
$79
Jan-06-20 Initiated
Craig Hallum
Buy
$40
Show Previous Ratings
Jun-25-26 01:55PM
Jun-23-26 09:15AM
Jun-22-26 05:07PM
Jun-18-26 11:27AM
Jun-17-26 09:47AM
07:05AM
Loading…
07:05AM
(Pharmaceutical Business Review)
Jun-16-26 09:00AM
Jun-01-26 04:17PM
May-21-26 04:05PM
May-06-26 07:55AM
Apr-21-26 07:55AM
Apr-20-26 07:55AM
Apr-10-26 08:30AM
06:26AM
03:00AM
04:11PM
Loading…
Apr-09-26 04:11PM
04:05PM
Mar-27-26 07:26AM
(Pharmaceutical Business Review)
Mar-26-26 04:05PM
07:55AM
Mar-10-26 05:15PM
Mar-07-26 11:02PM
Mar-03-26 07:55AM
Feb-26-26 12:06PM
Feb-15-26 07:31AM
Feb-09-26 06:45PM
Feb-04-26 09:10AM
Feb-03-26 04:05PM
Jan-30-26 09:52AM
Jan-29-26 10:12AM
07:47AM
Loading…
07:47AM
Jan-28-26 08:03AM
Jan-22-26 12:31PM
Jan-21-26 04:05PM
09:20AM
Jan-16-26 09:27AM
Jan-09-26 07:25AM
12:00AM
Jan-08-26 06:05PM
04:14PM
(Associated Press Finance)
04:05PM
09:39AM
Dec-22-25 09:53AM
Dec-18-25 12:00PM
07:50AM
Dec-17-25 07:50AM
Dec-09-25 08:35AM
07:55AM
Dec-04-25 12:50PM
08:56AM
Dec-02-25 03:40PM
09:06AM
12:00AM
Dec-01-25 04:32PM
(Associated Press Finance)
04:05PM
Nov-28-25 07:16AM
Nov-26-25 09:49AM
Nov-24-25 10:00AM
Nov-14-25 09:55AM
Nov-06-25 08:20PM
Nov-05-25 12:37PM
12:13PM
11:57AM
11:51AM
10:27AM
Nov-04-25 01:46PM
Nov-03-25 12:50PM
12:43PM
12:10PM
Oct-31-25 12:53PM
Oct-29-25 10:00AM
09:55AM
08:46AM
05:45AM
Oct-22-25 07:50AM
Oct-20-25 09:38AM
Oct-07-25 05:30AM
Sep-05-25 06:34PM
Aug-27-25 07:50AM
Aug-11-25 03:21PM
Aug-01-25 10:39AM
10:34AM
Jul-31-25 10:56AM
10:30AM
Jul-30-25 09:54AM
Jul-29-25 08:52AM
07:50AM
Jul-28-25 08:20AM
Jul-25-25 09:18AM
Jul-24-25 10:59AM
Jul-23-25 10:22AM
10:15AM
09:52AM
Jul-19-25 02:38AM
Jul-15-25 01:56PM
09:17AM
03:02AM
Jul-14-25 04:15PM
04:13PM
(Associated Press Finance)
04:05PM
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.
Chief Executive Officer Mr. Shawn M. O'Connor
CFO Mr. William Frederick
Chief Operating Officer Mr. Josh Fohey
Chief Revenue Officer Mr. John Anthony DiBella M.S.
President of Services Solutions Ms. Jill Fiedler-Kelly M.S.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Fiedler-Kelly Jill President, Services Solutions Jun 16 '26 Option Exercise 10.05 7,350 73,868 85,167 Jun 17 04:06 PM Fiedler-Kelly Jill President, Services Solutions Jun 16 '26 Sale 18.20 7,350 133,770 77,817 Jun 17 04:06 PM JILL FIEDLER-KELLY Officer Jun 16 '26 Proposed Sale 16.37 5,250 85,942 Jun 16 04:38 PM Fiedler-Kelly Jill President, Services Solutions Jun 15 '26 Option Exercise 10.05 1,050 10,552 78,867 Jun 16 04:06 PM Fiedler-Kelly Jill President, Services Solutions Jun 15 '26 Sale 16.51 1,050 17,336 77,817 Jun 16 04:06 PM JILL FIEDLER-KELLY Officer Jun 15 '26 Proposed Sale 16.32 3,150 51,408 Jun 15 04:50 PM DiBella John Anthony II Chief Revenue Officer Jun 03 '26 Sale 16.50 1,000 16,500 87,140 Jun 04 04:06 PM WOLTOSZ WALTER S Director Jun 01 '26 Sale 17.43 15,000 261,450 3,252,800 Jun 02 04:06 PM Walter S Woltosz & Virginia Ev Director Jun 01 '26 Proposed Sale 17.11 15,000 256,650 Jun 01 04:30 PM Fiedler-Kelly Jill President, Services Solutions May 11 '26 Option Exercise 10.05 1,000 10,050 78,817 May 13 04:07 PM Fiedler-Kelly Jill President, Services Solutions May 11 '26 Sale 16.53 1,000 16,530 77,817 May 13 04:07 PM JILL FIEDLER-KELLY Officer May 11 '26 Proposed Sale 16.68 1,000 16,680 May 11 04:34 PM DiBella John Anthony II Chief Revenue Officer May 04 '26 Sale 14.98 1,000 14,980 88,140 May 05 04:10 PM WOLTOSZ WALTER S Director May 04 '26 Sale 15.13 15,000 226,950 3,267,800 May 05 04:10 PM Walter S Woltosz & Virginia Ev Director May 04 '26 Proposed Sale 14.91 15,000 223,650 May 04 04:25 PM DiBella John Anthony II Chief Revenue Officer Apr 15 '26 Sale 13.37 1,000 13,370 89,140 Apr 16 04:09 PM JOHN ANTHONY DIBELLA II Officer Apr 15 '26 Proposed Sale 13.37 4,000 53,480 Apr 15 04:46 PM DiBella John Anthony II Chief Revenue Officer Feb 06 '26 Option Exercise 9.71 10,300 100,013 90,140 Feb 09 04:08 PM Fiedler-Kelly Jill President, Services Solutions Jan 28 '26 Option Exercise 9.71 8,950 86,905 77,817 Jan 29 04:05 PM LaVange Lisa Director Dec 01 '25 Sale 16.91 866 14,644 9,968 Dec 02 04:14 PM LISA LAVANGE Director Dec 01 '25 Proposed Sale 17.00 866 14,722 Dec 01 04:35 PM WOLTOSZ WALTER S Director Oct 01 '25 Sale 15.39 20,000 307,800 3,286,231 Oct 03 04:13 PM VIRGINIA EVANS WOLTOSZ & WALTE Director Oct 01 '25 Proposed Sale 15.07 20,000 301,400 Oct 01 04:29 PM LaVange Lisa Director Sep 02 '25 Sale 14.10 867 12,225 9,063 Sep 04 04:18 PM LaVange Lisa Director Aug 01 '25 Sale 12.93 867 11,210 9,930 Aug 04 04:21 PM LISA LAVANGE Director Aug 01 '25 Proposed Sale 13.02 1,734 22,577 Aug 01 04:29 PM WOLTOSZ WALTER S Director Jul 01 '25 Sale 18.33 20,000 366,623 3,304,157 Jul 02 04:24 PM VIRGINIA EVANS WOLTOSZ & WALTE Director Jul 01 '25 Proposed Sale 17.45 60,000 1,047,000 Jul 01 04:34 PM